---
schema_version: "secwatch.filing_event.v1"
accession: "0001683168-25-002591"
form_type: "8-K"
ticker: "RDNT"
cik: "0000790526"
company_name: "RadNet, Inc."
filed_at: "2025-04-15T23:59:59+00:00"
generated_at: "2026-05-23T15:13:46.985632+00:00"
event_type: "m_and_a"
sentiment: "positive"
materiality_score: 0.8
calibrated_materiality_score: 0.8
confidence: "high"
source: SEC EDGAR
---

# RadNet to acquire iCAD for ~$103M all-stock; ~98% premium

## Summary
- All-stock acquisition of iCAD for ~$103M (0.0677 RDNT shares per ICAD share); ~98% premium to ICAD's April 14 close.
- Expected close in Q2 or Q3 2025, subject to iCAD stockholder approval and customary conditions.
- Combines RadNet's DeepHealth with iCAD's ProFound Breast Health Suite; iCAD has 1,500+ provider locations across 50+ countries.
- RadNet will host conference call April 16 at 10:30 AM ET to discuss transaction.

## SEC filing metadata
- accession: 0001683168-25-002591
- form_type: 8-K
- ticker: RDNT
- cik: 0000790526
- company_name: RadNet, Inc.
- filed_at: 2025-04-15T23:59:59+00:00
- event_type: m_and_a
- sentiment: positive
- materiality_score: 0.8
- calibrated_materiality_score: 0.8
- confidence: high
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/790526/000168316825002591/0001683168-25-002591-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/790526/000168316825002591/radnet_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001683168-25-002591
- JSON: https://secwatch.observer/filing/0001683168-25-002591.json
- Plain text: https://secwatch.observer/filing/0001683168-25-002591.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.